Literature DB >> 14730181

Management pathways and the surgical diagnosis of tuberculous lymphadenitis: can they be improved? The Bradford experience.

A Tsikoudas1.   

Abstract

OBJECTIVE: To study the diagnostic pathway for tuberculous lymphadenitis from initial referral to the commencement of antituberculous therapy with the object of identifying potentially avoidable delays.
DESIGN: Retrospective case series study.
SETTING: District General Hospital, England, UK.
SUBJECTS: Thirty-four patients with head and neck tuberculous lymphadenitis diagnosed by a positive histological specimen over the 3-year period 1998-2000.
RESULTS: There were no clear pathways for referral and management. There were substantial variations in the management between different specialties and even sometimes within the same specialty. There was evidence of poor communication between various teams.
CONCLUSIONS: The study shows that for the management of head and neck tuberculous lymphadenitis, there is a need for a 'hospital' or 'trust' approach. It also reinforces the arguments for a dedicated 'neck lump clinic' with easy access both from the general practitioners and from other specialties within the hospital and for a protocol for handling biopsy specimens from nodes. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14730181     DOI: 10.1159/000075223

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  2 in total

1.  Waiting time to lymph node biopsy is dependent on referral method: don't write, phone!

Authors:  S A J Pannick; C L Ingham Clark
Journal:  Ann R Coll Surg Engl       Date:  2009-09-25       Impact factor: 1.891

2.  Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain.

Authors:  Xavier Bosch; Carmen Sanclemente-Ansó; Ona Escoda; Esther Monclús; Jonathan Franco-Vanegas; Pedro Moreno; Mar Guerra-García; Neus Guasch; Alfons López-Soto
Journal:  BMC Cancer       Date:  2018-03-12       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.